NeoGenomics, Inc.
NEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $187,797 | $181,330 | $168,035 | $172,000 |
| % Growth | 3.6% | 7.9% | -2.3% | – |
| Cost of Goods Sold | $107,351 | $104,072 | $94,789 | $94,743 |
| Gross Profit | $80,446 | $77,258 | $73,246 | $77,257 |
| % Margin | 42.8% | 42.6% | 43.6% | 44.9% |
| R&D Expenses | $8,694 | $9,023 | $10,181 | $7,969 |
| G&A Expenses | $69,874 | $71,747 | $68,207 | $63,643 |
| SG&A Expenses | $91,680 | $95,822 | $90,890 | $85,982 |
| Sales & Mktg Exp. | $21,806 | $24,075 | $22,683 | $22,339 |
| Other Operating Expenses | $7,086 | $20,041 | $0 | $1,707 |
| Operating Expenses | $107,460 | $124,886 | $101,071 | $95,658 |
| Operating Income | -$27,014 | -$47,628 | -$27,825 | -$18,401 |
| % Margin | -14.4% | -26.3% | -16.6% | -10.7% |
| Other Income/Exp. Net | $625 | $1,812 | $2,168 | $2,273 |
| Pre-Tax Income | -$26,389 | -$45,816 | -$25,657 | -$16,128 |
| Tax Expense | $740 | -$724 | $266 | -$804 |
| Net Income | -$27,129 | -$45,092 | -$25,923 | -$15,324 |
| % Margin | -14.4% | -24.9% | -15.4% | -8.9% |
| EPS | -1.05 | -1.75 | -1 | -0.6 |
| % Growth | 40% | -75% | -66.7% | – |
| EPS Diluted | -1.05 | -1.75 | -1 | -0.6 |
| Weighted Avg Shares Out | 25,583 | 25,590 | 25,475 | 25,332 |
| Weighted Avg Shares Out Dil | 25,583 | 25,590 | 25,475 | 25,332 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,563 | $2,263 | $3,721 | $4,328 |
| Interest Expense | $0 | $933 | $1,618 | $1,624 |
| Depreciation & Amortization | $16,437 | $17,264 | $17,728 | $18,188 |
| EBITDA | -$9,952 | -$27,619 | -$6,311 | $3,684 |
| % Margin | -5.3% | -15.2% | -3.8% | 2.1% |